Sentinel lymph nodes and planar scintigraphy and SPECT/CT in various types of tumours. Estimation of some factors influencing detection success

Nuclear Medicine Review

Volumn 16, Issue 1, 2013, Pages 17-25

  Kraft, Otakar ^a,b   Havel, Martin ^a  

^a UNIVERSITY HOSPITAL OSTRAVA   (Czech Republic)

^b UNIVERSITY OF OSTRAVA   (Czech Republic)

Author keywords

Breast cancer; Gynaecologic cancers; Lymphoscintigraphy; Melanoma; Planar scintigraphy; Sentinel node; SPECT CT

Indexed keywords

ADULT; ARTICLE; BODY MASS; BREAST CANCER; ENDOMETRIUM CANCER; FALSE POSITIVE RESULT; FEMALE; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MELANOMA; MORBIDITY; NUCLEAR MEDICINE TECHNICIAN; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UTERINE CERVIX CANCER; VULVA CARCINOMA;

AGE FACTORS; AGED; ARTIFACTS; BODY MASS INDEX; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOPLASMS; SENSITIVITY AND SPECIFICITY; SKIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879672114     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: 10.5603/NMR.2013.0004     Document Type: Article

References (61)

1. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct elective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer. Results of a pilot study. Gynecol Oncol 1996; 62: 169-173. (Pubitemid 26274795)
2. Nieweg OE, Jansen L, Valdés Olmos RA et al. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 1999; 26: S11-16. (Pubitemid 29171613)
3. Kraft O, Šafarčík K, Stȩpień A. Sentinel Lymph Node Detection and Biopsy in Breast Cancer and Malignant Melanoma. World J Nucl Med 2004; 3: 26-32.
4. Tanaka Y, Sawada S, Murata T. Relationship between lymph node metastases and prognosis in patients irradiated post-operatively for carcinoma of the uterine cervix. Acta Radiol 1984; 23: 455-459. (Pubitemid 15073560)
5. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathological study of disease free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990; 38: 352-357. (Pubitemid 20362555)
6. Estourgie SH, Nieweg OE, Valdés Olmos RA, Hoefnagel CA, Kroon BB. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003; 10: 681-688. (Pubitemid 40486901)
7. Vuylsteke RJ, Van Leeuwen PA, Statius Muller MG, Gietema HA, Kragt DR, Meijer S. Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol 2003; 21: 1057-1065. (Pubitemid 46594135)
8. Dickinson RL, Erwin WD, Stevens DM et al. Hybrid modality fusion of planar scintigrams and CT topograms to localize sentinel lymph nodes in breast lymphoscintigraphy: Technical description and phantom studies. Int J Mol Imaging 2011; ID: 298102.
9. van der Ploeg IM, Nieweg OE, Kroon BB et al. The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer. Eur J Nucl Med Mol Imaging 2009; 36: 903-909.
10. Sergieva S, Goranov K, Piperkova E et al. Role of radioimmunoscintigraphy and SPET in the diagnosis of patients with malignant melanoma. Nucl Med Commun 1994; 15: 168-172. (Pubitemid 24104353)
11. Kraft O. The sentinel lymph node. The influence of some factors on the detection success. Nucl Med Rev Cent East Eur 2004; 7: 221.
12. Kraft O, Urbanová E, Mergancová J et al. Lymphoscintigraphy in sentinel node identification in breast cancer. Detection with four types of radiopharmaceuticals. Abstracts of Annual Congress of the European Assocation of Nuclear Medicine 15.-19.10. 2005 Istanbul, Turkey. Eur J Nucl Med Mol Imaging 2005; 32: Suppl. 1, P75, S 138.
13. Kraft O, Ševčík L, Klát J, Koliba P, Čuřík R, Křížová H. Detection of sentinel lymph nodes in cervical cancer. A comparison of two protocols. Nucl Med Rev Cent East Eur 2006; 9: 65-68. (Pubitemid 44043675)
14. Kretschmer L, Altenvoerde G, Meller J et al. Dynamic lymphoscintigraphy and image fusion of SPECT and pelvic CT-scans allow mapping of aberrant pelvic sentinel lymph nodes in malignant melanoma. Eur J Cancer 2003; 39: 175-183. (Pubitemid 36057067)
15. Reintgen D, Cruse CW, Wells K et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994; 220: 759-767. (Pubitemid 24376374)
16. Hubalewska-Dydejczyk A, Sowa-Staszczak A, Huszno B. Current application of sentinel lymph node lymphoscintigraphy to detect various cancer metastases. Hell J Nucl Med 2006; 9 (1): 5-9.
17. Cheng G, Kurita S, Torigian DA, Alavi A. Current status of sentinel lymph-node biopsy in patients with breast cancer. Eur J Nucl Med Mol Imaging 2011; 38 (3): 562-575.
18. De Hullu JA, Hollema H, Piers DA et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000; 18: 2811-2816. (Pubitemid 30620069)
19. Levenback C, Coleman RL, Burke TW Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 2001; 83: 276-281. (Pubitemid 33033066)
20. Dargent D, Martin X, Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 2000; 79: 411-415.
21. Lambaudie E, Collinet P, Narducci F et al. Laparoscopic identification of sentinel lymph nodes in early stage cervical cancer: prospective study using a combination of patent blue dye injection and technetium radiocolloid injection. Gynecol Oncol 2003; 89: 84-87. (Pubitemid 36403651)
22. Lelièvre L, Camatte S, Le Frère-Belda MA et al. Sentinel lymph node biopsy in cervical and endometrial cancers. A feasibility study. Bull Cancer 2004; 91: 379-384. (Pubitemid 38662070)
23. Frumovitz M, Bodurka DC, Broaddus RR et al. Lymphatic mapping and sentinel node biopsy in women with high risk endometrial cancer. Gynecol Oncol 2007; 104: 100-103. (Pubitemid 46075145)
24. Klát J, Ševčík L, Šimetka O et al. Characteristics of sentinel lymph nodes' metastatic involvement in early stage of vulvar cancer. ANZJOG 2009; 49: 672-676.
25. Jansen L, Nieweg OE, Peterse JL, Hoefnagel CA, Olmos RA, Kroon BB. Reliability of sentinel node biopsy for staging melanoma. Br J Surg 2000; 87: 484-489. (Pubitemid 30192962)
26. Lyman GH, Giuliano AE, Somerfield MR et al. Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23 (30): 7703-7720. (Pubitemid 46291835)
27. Reeves ME, Coit DG. Melanoma. A multidisciplinary approach for the general surgeon. Surg Clin North Am 2000; 80: 581-601. (Pubitemid 30227071)
28. Shrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000; 88: 608-614. (Pubitemid 30056936)
29. Pijpers R, Buist MR, van Lingen A et al. The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy. Eur J Nucl Med Mol Imaging 2004; 31: 1479-1486.
30. Abu-Rustum NR, Alektiar K, Iasonos A et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol 2006; 103: 714-718. (Pubitemid 44602163)
31. Pandit-Taskar N, Gemignani ML, Lyall A, Larson SM, Barakat RR, Abu Rustum NR. Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy. Gynecol Oncol 2010; 117: 59-64.
32. Jansen L, Nieweg OE, Kapteijn AE et al. Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol 2000; 7: 624-630.
33. Martínez A, Zerdoud S, Mery E, Bouissou E, Ferron G, Querleu D. Hybrid imaging by SPECT/CT for sentinel lymph node detection in patients with cancer of the uterine cervix. Gynecol Oncol 2010; 119: 431-435.
34. van der Ploeg IM, Valdés Olmos RA, Kroon BB, Nieweg OE. The hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer. World J Surg 2008; 32: 1930-1934.
35. Even-Sapir E, Lerman H, Lievshitz G et al. Lymphoscintigraphy for sentinel node mapping using a hybrid SPECT/CT system. J Nucl Med 2003; 44: 1413-1420. (Pubitemid 39663353)
36. Keidar Z, Israel O, Krausz Y. SPECT/CT in tumor imaging: technical aspects and clinical applications. Semin Nucl Med 2003; 33: 205-218. (Pubitemid 36859499)
37. Seo Y, Mari C, Hasegawa BH. Technological development and advances in single-photon emission computed tomography/computed tomography. Semin Nucl Med 2008; 38: 177-198. (Pubitemid 351466914)
38. Bocher M, Balan A, Krausz Y et al. Gamma camera-mounted anatomical X-ray tomography: technology, system characteristics and first images. Eur J Nucl Med 2000; 27: 619-627. (Pubitemid 30408762)
39. Schillaci O. Hybrid SPECT/CT: a new era for SPECT imaging? Eur J Nucl Med Mol Imaging 2005; 32: 521-524. (Pubitemid 41214193)
40. Lieber KA, Standiford SB, Kuvshinoff BW, Ota DM. Surgical management of aberrant sentinel lymph node drainage in cutaneous melanoma. Surgery 1998; 124: 757-762. (Pubitemid 28463274)
41. Husarik DB, Steinert HC. Single-photon emission computed tomography/ computed tomography for sentinel node mapping in breast cancer. Semin Nucl Med 2007; 37: 29-33. (Pubitemid 44854757)
42. Kobayashi K, Ramirez PT, Kim EE et al. Sentinel node mapping in vulvovaginal melanoma using SPECT/CT lymphoscintigraphy. Clin Nucl Med 2009; 34: 859-861.
43. Khafif A, Schneebaum S, Fliss DM et al. Lymphoscintigraphy for sentinel node mapping using a hybrid single photon emission CT (SPECT)/CT system in oral cavity squamous cell carcinoma. Head Neck 2006; 28: 874-879. (Pubitemid 44497862)
44. Haerle SK, Stoeckli SJ. SPECT/CT for Lymphatic Mapping of Sentinel Nodes in Early Squamous Cell Carcinoma of the Oral Cavity and Oropharynx. Int J Mol Imaging 2011; Article ID 106068: 1-6.
45. Mariani G, Erba P, Manca G et al. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution. J Surg Oncol 2004; 85: 141-151. (Pubitemid 38313937)
46. Kizu H, Takayama T, Fukuda M et al. Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. J Nucl Med Technol 2005; 33: 78-82. (Pubitemid 44783742)
47. Sherif A, Garske U, de la Torre M, Thörn M. Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol 2006; 50: 83-91. (Pubitemid 43850119)
48. Mar VM, Miller SA, Kim EE, Macapinlac HA. Evaluation and localization of lymphatic drainage and sentinel lymph nodes in patients with head and neck melanomas by hybrid SPECT/CT lymphoscintigraphic imaging. J Nucl Med Technol 2007; 35: 10-16. (Pubitemid 47549649)
49. Beneder C, Fuechsel F, Krause T, Kuhn A, Mueller MD. The role of 3D fusion imaging in sentinel lymphadenectomy for vulvar cancer. Gynecol Oncol 2008; 109: 76-80.
50. Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E. Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging 2006; 33: 329-337.
51. Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E. Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med 2007; 48: 201-206. (Pubitemid 47555344)
52. Valdés-Olmos RA, Jansen L, Hoefnagel CA et al. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med 2000; 41: 1500-1506.
53. Byrd DR, Dunnwald LK, Mankoff DA et al. Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol 2001; 8: 234-240. (Pubitemid 32294804)
54. Valdés Olmos RA, Tanis PJ, Hoefnagel CA et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 2001; 22: 579-586. (Pubitemid 32458188)
55. Tanis PJ, van Sandick JW, Nieweg OE et al. The hidden sentinel node in breast cancer. Eur J Nucl Med Mol Imaging 2002; 29: 305-311.
56. van der Ploeg IMC, Valdés Olmos RA, Nieweg OE, Rutgers EJ, Kroon BB, Hoefnagel CA. The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med 2007; 48: 1756-1760. (Pubitemid 350099318)
57. Even-Sapir E. Sentinel node scintigraphic mapping using SPECT/CT. In: Israel O, Goldsmith S, eds. Hybrid SPECT/CT imaging in clinical practice. Taylor and Francis Group, New York 2006; 121-139.
58. Birdwell RL, Smith KL, Betts BJ et al. Visualization at preoperative lymphoscintigraphy. Radiology. 2001; 220: 47-53.
59. PMid:11425971.
60. Brenot-Rossi I, Houvenaeghel G, Jacquemier J et al. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer? J Nucl Med. 2003; 44: 1232-1237. (Pubitemid 39655182)
61. Ng PC, Chua AC, Lannin DP, et al. Age and surgeon experience: the only significant factors contributing to sentinel node mapping failure in breast cancer (abstr). Breast Cancer Res Treat. 1999; 57: 27.